vs
德康医疗（DXCM）与PLEXUS CORP（PLXS）财务数据对比。点击上方公司名可切换其他公司
德康医疗的季度营收约是PLEXUS CORP的1.1倍（$1.3B vs $1.2B），德康医疗净利率更高（21.2% vs 4.3%，领先16.9%），德康医疗同比增速更快（21.6% vs 18.7%），过去两年德康医疗的营收复合增速更高（12.0% vs 7.2%）
德康医疗是美国跨国医疗保健企业，专注于研发、生产及销售糖尿病管理领域的连续血糖监测（CGM）系列系统。其全球总部及研发中心位于美国加利福尼亚州圣地亚哥，生产基地分布于美国亚利桑那州梅萨、马来西亚峇都交湾及爱尔兰戈尔韦郡阿斯里。
Plexus Corp是总部位于美国密歇根州特洛伊市的软件企业，专注于开发及推广Plex制造云产品，这是一款面向制造行业的SaaS模式云计算ERP解决方案，可助力制造企业实现数字化运营管理升级。
DXCM vs PLXS — 直观对比
营收规模更大
DXCM
是对方的1.1倍
$1.2B
营收增速更快
DXCM
高出2.9%
18.7%
净利率更高
DXCM
高出16.9%
4.3%
两年增速更快
DXCM
近两年复合增速
7.2%
损益表 — Q1 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.3B | $1.2B |
| 净利润 | $267.3M | $49.8M |
| 毛利率 | 62.9% | 10.2% |
| 营业利润率 | 25.6% | 5.3% |
| 净利率 | 21.2% | 4.3% |
| 营收同比 | 21.6% | 18.7% |
| 净利润同比 | 153.6% | 27.5% |
| 每股收益（稀释后） | $0.67 | $1.82 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DXCMPLXS
| Q1 26 | $1.3B | $1.1B | ||
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.0B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $994.2M | — | ||
| Q2 24 | $1.0B | — |
净利润DXCMPLXS
| Q1 26 | $267.3M | $41.2M | ||
| Q4 25 | $267.3M | — | ||
| Q3 25 | $283.8M | — | ||
| Q2 25 | $179.8M | — | ||
| Q1 25 | $105.4M | — | ||
| Q4 24 | $151.7M | — | ||
| Q3 24 | $134.6M | — | ||
| Q2 24 | $143.5M | — |
毛利率DXCMPLXS
| Q1 26 | 62.9% | 9.9% | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | — | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | — | ||
| Q2 24 | 62.4% | — |
营业利润率DXCMPLXS
| Q1 26 | 25.6% | 5.1% | ||
| Q4 25 | 25.6% | — | ||
| Q3 25 | 20.1% | — | ||
| Q2 25 | 18.4% | — | ||
| Q1 25 | 12.9% | — | ||
| Q4 24 | 17.0% | — | ||
| Q3 24 | 15.3% | — | ||
| Q2 24 | 15.7% | — |
净利率DXCMPLXS
| Q1 26 | 21.2% | 3.8% | ||
| Q4 25 | 21.2% | — | ||
| Q3 25 | 23.5% | — | ||
| Q2 25 | 15.5% | — | ||
| Q1 25 | 10.2% | — | ||
| Q4 24 | 13.6% | — | ||
| Q3 24 | 13.5% | — | ||
| Q2 24 | 14.3% | — |
每股收益（稀释后）DXCMPLXS
| Q1 26 | $0.67 | $1.51 | ||
| Q4 25 | $0.67 | — | ||
| Q3 25 | $0.70 | — | ||
| Q2 25 | $0.45 | — | ||
| Q1 25 | $0.27 | — | ||
| Q4 24 | $0.37 | — | ||
| Q3 24 | $0.34 | — | ||
| Q2 24 | $0.35 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $917.7M | $303.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.7B | $1.5B |
| 总资产 | $6.3B | $3.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DXCMPLXS
| Q1 26 | $917.7M | $248.8M | ||
| Q4 25 | $917.7M | — | ||
| Q3 25 | $1.8B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $904.9M | — | ||
| Q4 24 | $606.1M | — | ||
| Q3 24 | $621.2M | — | ||
| Q2 24 | $939.2M | — |
股东权益DXCMPLXS
| Q1 26 | $2.7B | $1.5B | ||
| Q4 25 | $2.7B | — | ||
| Q3 25 | $2.7B | — | ||
| Q2 25 | $2.6B | — | ||
| Q1 25 | $2.3B | — | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | $2.0B | — | ||
| Q2 24 | $2.4B | — |
总资产DXCMPLXS
| Q1 26 | $6.3B | $3.2B | ||
| Q4 25 | $6.3B | — | ||
| Q3 25 | $7.5B | — | ||
| Q2 25 | $7.3B | — | ||
| Q1 25 | $6.8B | — | ||
| Q4 24 | $6.5B | — | ||
| Q3 24 | $6.4B | — | ||
| Q2 24 | $6.8B | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DXCM
暂无分部数据
PLXS
| Asia-Pacific | $652.0M | 56% |
| Americas | $397.0M | 34% |
| Europe, Middle East and Africa | $116.0M | 10% |
